Story perspectives

Breakthrough CRISPR Platform Boosts Natural Killer Cell Cancer Therapy

8/23/2025

45 6

Summary

Story summary

Researchers at The University of Texas MD Anderson Cancer Center created PreCiSE, a CRISPR screening platform for natural killer (NK) cells.
This platform identifies genetic regulators that enhance NK cell activity and counteract tumor microenvironment suppression.
Key genes identified include MED12, ARIH2, and CCNC, which will inform future NK cell therapy designs.
PreCiSE aims to improve NK therapies for various cancers, potentially advancing cancer immunotherapy.

1 of 1

Story summary

Researchers at The University of Texas MD Anderson Cancer Center created PreCiSE, a CRISPR screening platform for natural killer (NK) cells.
This platform identifies genetic regulators that enhance NK cell activity and counteract tumor microenvironment suppression.
Key genes identified include MED12, ARIH2, and CCNC, which will inform future NK cell therapy designs.
PreCiSE aims to improve NK therapies for various cancers, potentially advancing cancer immunotherapy.